Galapagos acquires UCL spin out in €12.5M all-share deal Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million. 12 Dec 2006 News